| This week's sponsor is Premier Research. | | | >From Lab to Bedside: The Latest Rare Oncology Drug Research
Study of rare cancers demands immersion in dual indications where strategies often don't mesh. Attend our Feb. 28 webinar for fresh insights on speeding development of new drugs. Register now. Premier Research. It's what we do. Best. |
Top Stories Wednesday, February 8, 2017 Billionaire husband-and-wife team Priscilla Chan and Facebook founder Mark Zuckerberg have stumped up around $50 million to fund 47 "CZ Biohub" investigators from across U.S. academia. Wednesday, February 8, 2017 Lundbeck is calling time on development of Alzheimer’s candidate idalopirdine after it chalked up a clean sweep of failures in phase 3. The Danish drugmaker made the decision after learning the 5-HT6 agonist, which failed its first phase 3 in September, had come up short in its second and third late-stage studies. Wednesday, February 8, 2017 Shanghai-based startup Abbisko Therapeutics has raised $28 million in a Series A financing that will be used to advance its cancer immunotherapies into clinical trials. Wednesday, February 8, 2017 Intensix, which is harnessing machine learning in the ICU, reeled in an $8.3 million Series A. The funds are pegged for the expansion of its sales and marketing ops in North America as well as further development of its predictive analytics platform. | | | Sanofi said in its financials this morning that it plans for a resubmission of its FDA-delayed arthritis candidate sarilumab in the first quarter. Release The FDA has given its fast-track tag to Angionetics' one-time gene therapy in patients with coronary heart disease. Statement Takeda has handed over $1 million as a gift to the Koch Institute for Integrative Cancer Research at MIT to help it with immuno-oncology research. Release | |
|
Resources Sponsored By: Veeva Learn over a dozen best practices for deploying a global content system. Read Whitepaper. Sponsored By: Veeva Gartner provides insightful research on preparing for IDMP compliance. Read Whitepaper. Sponsored By: Veeva Learn How to Create a Unified RIM Environment for IDMP. Find out. Sponsored By: Veeva The largest survey of TMF owners reveals drivers and trends in improving inspection readiness and shortening trial time. Sponsored By: Salesforce Learn how the healthcare and life science industry is using agile application development to drive innovation and accelerate their business with the Salesforce Platform. Presented by: Patheon Can you avoid a risky trial-and-error approach to find the right path for your poorly soluble molecule by utilizing a CDMO? Download this complimentary Whitepaper to learn more! BIO CEO & Investor Conference February 13 – 14, 2017 | The Waldorf Astoria, New York, NY Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA PEGS: The Essential Protein Engineering Summit May 1-5, 2017 | Boston, MA | 